J. B. Chemicals & Pharmaceuticals Limited EBITDA for the year ending March 31, 2025: USD 120.75 M

J. B. Chemicals & Pharmaceuticals Limited EBITDA is USD 120.75 M for the year ending March 31, 2025, a 7.89% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • J. B. Chemicals & Pharmaceuticals Limited EBITDA for the year ending March 31, 2024 was USD 111.92 M, a 30.59% change year over year.
  • J. B. Chemicals & Pharmaceuticals Limited EBITDA for the year ending March 31, 2023 was USD 85.70 M, a 11.90% change year over year.
  • J. B. Chemicals & Pharmaceuticals Limited EBITDA for the year ending March 31, 2022 was USD 76.59 M, a -16.58% change year over year.
  • J. B. Chemicals & Pharmaceuticals Limited EBITDA for the year ending March 31, 2021 was USD 91.81 M, a 65.38% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)